Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit - Carekit Offers Acne Patients Simple and Convenient Moisturizing Option  
8/4/2009 8:05:28 AM

BRIDGEWATER, N.J., Aug. 4 /PRNewswire-FirstCall/ -- With acne being one of the most common skin diseases affecting nearly 80 percent of people between the ages of 12 and 24, Dermik Laboratories, a business of sanofi-aventis U.S., announced today the availability of the BenzaClin(R) (clindamycin 1%-benzoyl peroxide 5% gel) carekit, a unique prescribing option for patients with acne who want to add a moisturizing agent to their skin care regimen.